Evidence map›Paper›PMID 38665242›Full record

ArticleFrontiers in public health2024

Understanding HIV/AIDS dynamics: insights from CD4+T cells, antiretroviral treatment, and country-specific analysis.

Dipo Aldila, Ranandha P Dhanendra, Sarbaz H A Khoshnaw, Juni Wijayanti Puspita, Putri Zahra Kamalia, Muhammad Shahzad

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Dipo AldilaDepartment of Mathematics, Universitas Indonesia, Depok, Indonesia.
Ranandha P DhanendraDepartment of Mathematics, Universitas Indonesia, Depok, Indonesia.
Sarbaz H A KhoshnawDepartment of Mathematics, University of Raparin, Ranya, Iraq.
Juni Wijayanti PuspitaDepartment of Mathematics, Universitas Tadulako, Palu, Indonesia.
Putri Zahra KamaliaDepartment of Mathematics, Universitas Indonesia, Depok, Indonesia.
Muhammad ShahzadDepartment of Mathematics and Statistics, The University of Haripur, Haripur, KP, Pakistan.
University of Indonesia · IDTadulako University · IDUniversity of Haripur · PKUniversity of Raparin · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we present a mathematical model for human immunodeficiency virus (HIV)/Acquired immune deficiency syndrome (AIDS), taking into account the number of CD4+T cells and antiretroviral treatment. This model is developed based on the susceptible, infected, treated, AIDS (SITA) framework, wherein the infected and treated compartments are divided based on the number of CD4+T cells. Additionally, we consider the possibility of treatment failure, which can exacerbate the condition of the treated individual. Initially, we analyze a simplified HIV/AIDS model without differentiation between the infected and treated classes. Our findings reveal that the global stability of the HIV/AIDS-free equilibrium point is contingent upon the basic reproduction number being less than one. Furthermore, a bifurcation analysis demonstrates that our simplified model consistently exhibits a transcritical bifurcation at a reproduction number equal to one. In the complete model, we elucidate how the control reproduction number determines the stability of the HIV/AIDS-free equilibrium point. To align our model with the empirical data, we estimate its parameters using prevalence data from the top four countries affected by HIV/AIDS, namely, Eswatini, Lesotho, Botswana, and South Africa. We employ numerical simulations and conduct elasticity and sensitivity analyses to examine how our model parameters influence the control reproduction number and the dynamics of each model compartment. Our findings reveal that each country displays distinct sensitivities to the model parameters, implying the need for tailored strategies depending on the target country. Autonomous simulations highlight the potential of case detection and condom use in reducing HIV/AIDS prevalence. Furthermore, we identify that the quality of condoms plays a crucial role: with higher quality condoms, a smaller proportion of infected individuals need to use them for the potential eradication of HIV/AIDS from the population. In our optimal control simulations, we assess population behavior when control interventions are treated as time-dependent variables. Our analysis demonstrates that a combination of condom use and case detection, as time-dependent variables, can significantly curtail the spread of HIV while maintaining an optimal cost of intervention. Moreover, our cost-effectiveness analysis indicates that the condom use intervention alone emerges as the most cost-effective strategy, followed by a combination of case detection and condom use, and finally, case detection as a standalone strategy.

Indexed as

CD4-Positive T-LymphocytesHIV InfectionsAcquired Immunodeficiency SyndromeAnti-HIV AgentsAnti-Retroviral AgentsBasic Reproduction NumberCD4 Lymphocyte CountHumansModels, TheoreticalPrevalenceAnti-HIV AgentsAnti-Retroviral Agentsantiretroviral treatmentcondomcost-effectivenessglobal stabilityHIV/AIDSoptimal controlsensitivity analysis

Identifiers

PMID38665242
PMCPMC11043473
OpenAlexW4394723028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.